Probiotic Supplements Market
Probiotic Supplements Market Size, Share & Industry Analysis, By Form (Capsules, Tablets, Powder, Liquid), By Application (Digestive Health, Immunity, Women's Health, Weight Management), By Distribution Channel (Supermarkets/Hypermarkets, Pharmacies, Online Retail, Specialty Stores), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview:
The Probiotic Supplements Market is projected to grow at a CAGR of 7.3% from 2024 to 2031. The market value is expected to increase from USD XX billion in 2024 to USD YY billion by 2031.
North America currently dominates the market, with key metrics including increasing consumer awareness about gut health, rising prevalence of digestive disorders, and growing demand for preventive healthcare solutions. The market is experiencing robust growth driven by the expanding scientific evidence supporting probiotic benefits, increasing health-conscious population, and innovations in probiotic strains and delivery formats.
Probiotic Supplements Market Dynamics:
Market Trend: Rising demand for condition-specific probiotic formulations
The probiotic supplement industry is shifting dramatically towards condition-specific products. Consumers are increasingly looking for probiotic supplements that address specific health conditions as well as overall digestive health. This movement is being driven by growing consumer awareness of probiotics' varied health benefits, as well as advancements in microbiome research. For example, probiotic formulations aimed at mental health, skin health, and cardiovascular health are becoming increasingly popular. A new study published in the Journal of Clinical Medicine discovered that certain probiotic strains can reduce anxiety and depression symptoms by up to 50% in some persons. As a result, "psychobiotics"--probiotic pills intended expressly to improve mental health--have emerged. Similarly, probiotic skincare supplements have gained in popularity, and the global probiotic cosmetics market is expected to reach $300 million by 2025. Major probiotic manufacturers are responding to this trend by broadening their product offerings to include these specialist formulations, resulting in greater innovation and market growth in this area.
Market Driver: Increasing scientific evidence supporting probiotic efficacy
The growing body of scientific evidence supporting the health benefits of probiotics is a primary driver of the probiotic supplement industry. Numerous clinical studies have proved the benefits of probiotics in a wide range of health applications, resulting in increasing consumer confidence and recommendations from healthcare professionals. According to studies conducted by the International Scientific Association for Probiotics and Prebiotics, the number of published clinical trials on probiotics has increased by 300% over the last decade. This rise in scientific knowledge has backed established applications while also revealing new potential uses for probiotics. For example, a crucial study published in Nature in 2023 discovered that some probiotic strains could boost the efficiency of cancer immunotherapy, thus opening up a new business sector for probiotic supplements in oncology. Furthermore, health institutions are increasingly realising the benefits of probiotics. The World Gastroenterology Organisation now recommends probiotics for a wide range of gastrointestinal illnesses, including irritable bowel syndrome and antibiotic-associated diarrhoea. This growing scientific validation and institutional support is driving consumer demand as well as recommendations from healthcare professionals for probiotic supplements.
Market Restraint: Regulatory challenges and product quality concerns
One of the most major challenges confronting the probiotic supplement business is the complex and frequently changing regulatory landscape across several areas, as well as concerns about product quality and efficacy. In many countries, probiotics are classified as both foods and drugs, causing uncertainty in product claims and marketing. For example, the European Food Safety Authority (EFSA) has adopted a strong stance on probiotic health claims, rejecting multiple applications due to a lack of scientific evidence. This legislative hurdle has limited firms' ability to communicate the benefits of their products to clients in the European market. Furthermore, there are concerns about the quality and efficacy of probiotic supplements on the market. A study published in Frontiers in Medicine in 2022 found that only 43% of tested probiotic pills had the same species and strains listed on the labels, raising concerns about product purity and efficacy. These quality problems may erode consumer trust and stymie industry growth. Another concern is maintaining probiotic viability during the product's shelf life, as some studies show large reductions in live microbe counts in supplements over time. These regulatory and quality challenges are prompting the industry to invest in more stringent quality control methods and fight for clearer, more harmonised regulations to ensure product integrity and consumer trust.
Segment Overview:
Capsules dominate the Probiotic Supplements Market due to their convenience, precise dosing, and ability to protect probiotic strains from stomach acid.
Probiotic supplements in capsule form have emerged as the market's dominating segment, accounting for the vast majority of the market share. This dominance may be attributed to a variety of variables, including capsules' usefulness as a delivery route for probiotic supplements.
First and foremost, capsules provide customers a convenient and familiar method of replenishment. They are easy to ingest, transport, and incorporate into daily activities. This convenience aspect is especially important for probiotic pills, which must be taken daily to maintain their advantages.
Second, capsules allow for proper dosing of probiotic strains. Each capsule contains a consistent amount of probiotics, ensuring that consumers receive the optimum dose with each serving. This precision is crucial for the efficacy of probiotic supplements, allowing for more accurate clinical research and recommendations.
Furthermore, capsules offer better protection for probiotic strains against harsh stomach acids. Many probiotic capsules include coatings or technology that keep live bacteria from degrading in the stomach, allowing them to colonise and exert their therapeutic benefits in the intestine. For example, a well-known probiotic business has introduced a novel capsule technology that allegedly increases the survival rate of probiotic strains in the stomach by up to 250% when compared to regular capsules.
Recent technological advancements have benefited the capsule sector as well. For example, the development of delayed-release capsules has improved the efficiency of probiotic supplements by allowing for targeted delivery to specific areas of the gut. A study published in the Journal of Functional Foods in 2023 discovered that delayed-release probiotic capsules resulted in a 40% higher colonisation rate of beneficial bacteria than normal capsules.
Furthermore, capsules allow for the combination of many strains and other nutrients, such as prebiotics, in a single dose. This versatility has enabled companies to create more extensive and personalised probiotic formulations. For example, in 2023, a leading probiotic business released a multi-strain probiotic capsule that combines five clinically tested probiotic strains with prebiotics and vitamins, in response to increased customer demand for all-in-one gut health solutions.
Consumer behaviour and market data indicate a preference for capsules. A poll conducted by a major market research organisation in 2022 revealed that 62% of probiotic supplement customers preferred capsules over other forms, citing ease of use and perceived effectiveness as the top reasons. This consumer preference has motivated major probiotic supplement manufacturers to focus their product research and marketing efforts on capsule formulations, maintaining the segment's dominant market position.
Regional Outlook:
North America leads the Probiotic Supplements Market, driven by high consumer awareness, strong healthcare infrastructure, and innovative product offerings.
North America's dominance in the probiotic supplement sector can be attributed to a variety of factors, including a health-conscious consumer base, a robust healthcare infrastructure, and a supportive regulatory environment for dietary supplements. The area, particularly the United States, has led the way in probiotic research and product innovation, allowing it to maintain market supremacy.
The high level of awareness among North American consumers regarding the health benefits of probiotics has been a key driver of market growth. In 2023, the International Food Information Council conducted a research that revealed that 76% of American consumers were aware of probiotics, with 45% actively searching out probiotic-containing products. This awareness has resulted in a significant demand for probiotic supplements in a wide range of health applications.
Recent changes in the North American market reaffirm its leadership position. In 2023, a well-known probiotic firm in the United States introduced a new probiotic pill that combines specific strains that target both gut and brain health, capitalising on the growing interest in the gut-brain axis. This product has been quickly adopted, particularly by health-conscious millennials and Generation Z consumers.
The retail landscape for probiotic supplements in North America has also evolved substantially. While pharmacies and health food stores remain important distribution channels, online retail has grown significantly. According to industry projections, e-commerce sales of probiotic supplements in the United States will grow by 35% in 2022, owing to the convenience of online shopping and access to a wider range of products.
Key data demonstrates North America's market dominance. According to Aurorawave Intellects Research, North America represents more than YY% of the global probiotic supplement market. The US probiotic supplement market was worth $YY billion in 2022, with projections of $YY billion by 2031. Furthermore, according to a Natural Marketing Institute report, 25% of people in the United States take probiotic supplements on a daily basis, a figure that has risen over the last decade.
The region has also made significant expenditures in probiotics research and development. The US National Institutes of Health will invest $50 million in microbiome research in 2023, including studies on probiotic applications, strengthening North America's position as a probiotic innovation hub.
Canada has made significant contributions to the region's commercial leadership. Over the previous three years, probiotic supplement sales in the country have climbed by 15% year on year, owing to rising consumer interest in preventative healthcare and government support for natural health products.
Competitive Intelligence:
The probiotic supplements sector is marked by severe competition among major players, each striving to innovate and expand their market share through product development, strategic collaborations, and global growth. Leading companies in this field include Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Probi AB, and Nestlé S.A. These corporations have solidified their positions by combining scientific expertise, wide product portfolios, and global distribution networks.
Market leaders are focussing on developing new probiotic strains and formulations to address specific health concerns. Chr. Hansen, for example, has launched a probiotic strain clinically shown to aid in weight control, capitalising on the growing market for metabolic health supplements. This approach has been well received, particularly in North America and Europe, where obesity is common.
Mergers and acquisitions have drastically altered the competitive landscape. Nestlé S.A. plans to acquire a majority stake in a promising probiotic start-up in 2022, strengthening its position in the functional foods and supplements business. This acquisition has increased Nestlé's probiotic product portfolio and microbiome research capabilities.
The market has also seen an increase in strategic relationships between probiotic companies and academic institutions. Danone S.A., for example, has partnered with a prominent institution to study the impact of probiotics on immune health in the elderly. Such agreements enable firms to leverage academic expertise and accelerate innovation processes.
Product diversity and value-added services are emerging as key competitive tactics. Companies are not only focused on the efficacy of their probiotic strains, but also on delivering comprehensive gut health solutions such as customised nutrition advice and microbiome testing. For example, Probi AB has developed a digital platform that provides clients with tailored probiotic recommendations based on their health profiles and lifestyle preferences.
Looking ahead, the competitive landscape is expected to evolve as the emphasis switches to next-generation probiotics and postbiotics. Companies are investing in R&D to discover new beneficial microbial strains and metabolites that may have further health benefits. This trend is projected to create new opportunities for market differentiation and growth in the next years.
Analyst Opinion:
The Probiotic Supplements Market is likely to have significant growth and innovation in the next years. One key trend to watch is the increased use of artificial intelligence and big data analytics in probiotic research and product development. These technologies enable firms to more efficiently discover novel probiotic strains and provide customised probiotic products based on individual microbiome characteristics.
Another important development is the growing popularity of synbiotic products, which contain probiotics, prebiotics, and other complementary ingredients. This strategy aligns with the industry's shift towards more holistic gut health products and may offer additional benefits to consumers.
The market is also expected to place a larger emphasis on sustainability and eco-friendly packaging. As consumers become more environmentally conscious, probiotic supplement manufacturers must adapt their manufacturing and packaging practices to meet changing demands.
Finally, the potential for probiotics in new health sectors, such as mental health and skin health, provides enormous market growth opportunities. As research in these areas progresses, we can anticipate a new generation of distinct probiotic medicines that treat these specific health concerns.
Major Players:
-
Chr. Hansen Holding A/S
-
Danone S.A.
-
Yakult Honsha Co., Ltd.
-
Probi AB
-
Nestlé S.A.
-
BioGaia AB
-
Protexin
-
Probiotics International Ltd
-
Lallemand Inc.
-
DuPont de Nemours, Inc.
Key Developments:
-
Chr. Hansen will launch a new probiotic strain clinically proven to boost immune function in children in July 2023, intending to capitalise on the thriving paediatric supplement industry.
-
October 2023: Danone S.A. announced a partnership with a leading e-commerce platform to increase the online distribution of its probiotic supplements in Asia-Pacific.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)
5. COMPANY PROFILES
5.1. Chr. Hansen Holding A/S
5.2. Danone S.A.
5.3. Yakult Honsha Co., Ltd.
5.4. Probi AB
5.5. Nestlé S.A.
5.6. BioGaia AB
5.7. Protexin
5.8. Probiotics International Ltd
5.9. Lallemand Inc.
5.10. DuPont de Nemours, Inc. (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Rising demand for condition-specific probiotic formulations
6.1.2. Integration of AI and big data analytics in probiotic research
6.1.3. Growing interest in synbiotic products
6.2. Market Drivers
6.2.1. Increasing scientific evidence supporting probiotic efficacy
6.2.2. Rising consumer awareness about gut health
6.2.3. Innovations in probiotic strains and delivery formats
6.3. Market Restraints
6.3.1. Regulatory challenges and product quality concerns
6.3.2. High cost of research and development for new probiotic strains
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY FORM (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Capsules
7.2. Tablets
7.3. Powder
7.4. Liquid
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Digestive Health
8.2. Immunity
8.3. Women's Health
8.4. Weight Management
9. BY DISTRIBUTION CHANNEL (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Supermarkets/Hypermarkets
9.2. Pharmacies
9.3. Online Retail
9.4. Specialty Stores
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031
Probiotic Supplements Market Segmentation:
By Form:
-
Capsules
-
Tablets
-
Powder
-
Liquid
By Application:
-
Digestive Health
-
Immunity
-
Women's Health
-
Weight Management
By Distribution Channel:
-
Supermarkets/Hypermarkets
-
Pharmacies
-
Online Retail
-
Specialty Stores
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511